GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $643,000 | +10.7% | 14,761 | +10.7% | 0.00% | 0.0% |
| Q1 2022 | $581,000 | -69.2% | 13,337 | -68.8% | 0.00% | -50.0% |
| Q4 2021 | $1,885,000 | +15.6% | 42,767 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,630,000 | +19.4% | 42,621 | +24.3% | 0.00% | 0.0% |
| Q2 2021 | $1,365,000 | +4.9% | 34,283 | -5.9% | 0.00% | 0.0% |
| Q1 2021 | $1,301,000 | -5.6% | 36,434 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $1,378,000 | -10.1% | 37,422 | -8.0% | 0.00% | -33.3% |
| Q3 2020 | $1,532,000 | -0.1% | 40,694 | +8.3% | 0.00% | -25.0% |
| Q2 2020 | $1,533,000 | +10.1% | 37,565 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $1,393,000 | -22.1% | 36,746 | -3.4% | 0.00% | -20.0% |
| Q4 2019 | $1,788,000 | +10.0% | 38,043 | -0.1% | 0.01% | 0.0% |
| Q3 2019 | $1,626,000 | +8.0% | 38,097 | +1.3% | 0.01% | +25.0% |
| Q2 2019 | $1,505,000 | -7.2% | 37,621 | -3.0% | 0.00% | -20.0% |
| Q1 2019 | $1,621,000 | +5.3% | 38,792 | -3.8% | 0.01% | 0.0% |
| Q4 2018 | $1,540,000 | -11.6% | 40,310 | -7.0% | 0.01% | 0.0% |
| Q3 2018 | $1,742,000 | +7.9% | 43,366 | +8.3% | 0.01% | 0.0% |
| Q2 2018 | $1,614,000 | +0.3% | 40,031 | -2.8% | 0.01% | 0.0% |
| Q1 2018 | $1,609,000 | -50.6% | 41,168 | -55.1% | 0.01% | -50.0% |
| Q4 2017 | $3,255,000 | -29.3% | 91,763 | -19.1% | 0.01% | -33.3% |
| Q3 2017 | $4,603,000 | +8.6% | 113,358 | +15.4% | 0.02% | +15.4% |
| Q2 2017 | $4,237,000 | +1.3% | 98,241 | -1.0% | 0.01% | -7.1% |
| Q1 2017 | $4,181,000 | +7.7% | 99,191 | -1.6% | 0.01% | 0.0% |
| Q4 2016 | $3,883,000 | -11.3% | 100,830 | -0.7% | 0.01% | -6.7% |
| Q3 2016 | $4,379,000 | -1.8% | 101,539 | -1.3% | 0.02% | -6.2% |
| Q2 2016 | $4,459,000 | -4.1% | 102,895 | -10.3% | 0.02% | 0.0% |
| Q1 2016 | $4,649,000 | +83.0% | 114,664 | +82.1% | 0.02% | +77.8% |
| Q4 2015 | $2,541,000 | +12.0% | 62,961 | +6.7% | 0.01% | +12.5% |
| Q3 2015 | $2,269,000 | +11.6% | 59,022 | +20.9% | 0.01% | +14.3% |
| Q2 2015 | $2,033,000 | -22.3% | 48,831 | -13.8% | 0.01% | -12.5% |
| Q1 2015 | $2,616,000 | -8.7% | 56,680 | -15.5% | 0.01% | -11.1% |
| Q4 2014 | $2,865,000 | -13.0% | 67,049 | -6.4% | 0.01% | -18.2% |
| Q3 2014 | $3,293,000 | -13.0% | 71,642 | +1.2% | 0.01% | -8.3% |
| Q2 2014 | $3,787,000 | -0.2% | 70,801 | -0.3% | 0.01% | 0.0% |
| Q1 2014 | $3,794,000 | +0.8% | 71,017 | +0.7% | 0.01% | 0.0% |
| Q4 2013 | $3,763,000 | +7.1% | 70,499 | +0.6% | 0.01% | -7.7% |
| Q3 2013 | $3,515,000 | +5.2% | 70,081 | +4.8% | 0.01% | 0.0% |
| Q2 2013 | $3,342,000 | – | 66,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |